Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9717740 | ETON | Treatment of adrenal insufficiency |
Nov, 2032
(9 years from now) | |
US9675559 | ETON | Treatment of adrenal insufficiency |
Jan, 2033
(9 years from now) | |
US9649280 | ETON | Composition comprising hydrocortisone |
May, 2034
(10 years from now) |
Market Authorisation Date: 29 September, 2020
Treatment: Treatment of adrenal insufficiency
Dosage: GRANULE;ORAL
6
United Kingdom
3
Japan
3
United States
2
Poland
2
Canada
2
Slovenia
2
Korea, Republic of
2
Brazil
2
Hong Kong
2
Lithuania
2
RS
2
Denmark
2
Croatia
2
Hungary
2
Spain
2
Australia
2
South Africa
2
Portugal
2
Israel
2
European Union
1
China
1
Mexico
1
New Zealand
1
Russia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic